NCT07088185进行中(未招募)不适用
Pulmonary Outcomes on Patients With Lung Fibrosis
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- FVC
研究概览
简要总结
The pulmonary fibrosis is lung disease that occurs when lung tissue become damaged and scarred. The objectives of treatment are to improve symptoms and quality of life, and slow disease progression.
详细描述
This study will include 60 patients with pulmonary fibrosis from both gender who are aged from 35 - 55 years old.This study will be randomized controlled trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 35 Years 至 55 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •both gender.
- •patients with cystic fibrosis.
排除标准
- •severe chronic disorders.
- •heart failure
- •respiratory failure.
- •age less than 35 or older than 55 years old.
结局指标
主要结局
FVC
时间窗: One month
Forced vital capacity (FVC).
FEV1
时间窗: One month
Forced expiratory volume in the first second (FEV1)
The FEV1 on FVC
时间窗: One month.
The ratio between FEV1 and FVC
次要结局
未报告次要终点
研究者
Shymaa yussuf abo zaid
Lecturer
South Valley University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prospective Observation of Fibrosis in the Lung Clinical Endpoints StudyIdiopathic Non-specific Interstitial PneumonitisIdiopathic Pulmonary FibrosisNCT01110694Royal Brompton & Harefield NHS Foundation Trust230
已完成
不适用
Pulmonary Fibrosis and Telomerase Mutation StudyPulmonary FibrosisNCT01501578Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires81
已完成
不适用
Lung Disease Associated With Rheumatoid ArthritisPulmonary FibrosisNCT00001876National Human Genome Research Institute (NHGRI)132
已完成
不适用
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid ArthritisHealthyRheumatoid ArthritisPulmonary FibrosisNCT00001885National Heart, Lung, and Blood Institute (NHLBI)400
招募中
不适用
Pulmonary Fibrosis Foundation Community RegistryLung FibrosisIdiopathic Pulmonary FibrosisPulmonary FibrosisInterstitial Lung DiseaseNCT05382572Pulmonary Fibrosis Foundation10,000
